Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 5.1% Last Week
Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 5.1% Last Week
Key Insights
關鍵見解
- Mayinglong Pharmaceutical Group's significant retail investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 16 shareholders own 50% of the company
- 21% of Mayinglong Pharmaceutical Group is held by Institutions
- 馬英龍製藥集團擁有大量散戶投資者的所有權表明,關鍵決策受到廣大公衆股東的影響
- 前16名股東擁有公司50%的股份
- 馬應龍藥業集團21%的股份由機構持有
To get a sense of who is truly in control of Mayinglong Pharmaceutical Group Co., Ltd. (SHSE:600993), it is important to understand the ownership structure of the business. With 44% stake, retail investors possess the maximum shares in the company. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
要了解誰真正控制了馬應龍藥業集團有限公司(SHSE: 600993),了解業務的所有權結構非常重要。散戶投資者持有該公司44%的股份,是公司的最大股份。換句話說,該集團將從對公司的投資中獲得最多(或損失最大)。
As a result, retail investors collectively scored the highest last week as the company hit CN¥11b market cap following a 5.1% gain in the stock.
結果,散戶投資者上週集體得分最高,該公司的市值在股價上漲5.1%後達到110億元人民幣。
Let's take a closer look to see what the different types of shareholders can tell us about Mayinglong Pharmaceutical Group.
讓我們仔細看看不同類型的股東能告訴我們關於馬英龍製藥集團的哪些信息。
Check out our latest analysis for Mayinglong Pharmaceutical Group
查看我們對馬英龍藥業集團的最新分析
![ownership-breakdown](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231116/0-b71095bf75477d273967fdce7855b285-0-c42bad291679383cc261447f7ab4e63d.png/big)
What Does The Institutional Ownership Tell Us About Mayinglong Pharmaceutical Group?
機構所有權告訴我們關於馬英龍藥業集團的什麼?
Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.
機構在向自己的投資者報告時通常會根據基準進行自我衡量,因此,一旦股票被納入主要指數,他們通常會變得更加熱情。我們預計大多數公司都會有一些機構在冊上,尤其是在它們正在成長的情況下。
We can see that Mayinglong Pharmaceutical Group does have institutional investors; and they hold a good portion of the company's stock. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Mayinglong Pharmaceutical Group, (below). Of course, keep in mind that there are other factors to consider, too.
我們可以看到,馬應龍藥業集團確實有機構投資者;他們持有該公司很大一部分股票。這表明專業投資者有一定的信譽。但是我們不能僅僅依靠這個事實,因爲機構有時會像所有人一樣進行不良投資。如果兩個大型機構投資者試圖同時拋售股票,股價大幅下跌的情況並不少見。因此,值得檢查一下馬應龍藥業集團過去的收益軌跡(見下文)。當然,請記住,還有其他因素需要考慮。
![earnings-and-revenue-growth](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231116/0-b71095bf75477d273967fdce7855b285-1-bd8999e84058ca0086f375464cba73fe.png/big)
We note that hedge funds don't have a meaningful investment in Mayinglong Pharmaceutical Group. The company's largest shareholder is China Baoan Group Co., Ltd., with ownership of 29%. Meanwhile, the second and third largest shareholders, hold 5.2% and 3.2%, of the shares outstanding, respectively.
我們注意到,對沖基金沒有對馬應龍製藥集團進行有意義的投資。公司的最大股東是中國寶安集團有限公司,擁有29%的股權。同時,第二和第三大股東分別持有已發行股份的5.2%和3.2%。
A closer look at our ownership figures suggests that the top 16 shareholders have a combined ownership of 50% implying that no single shareholder has a majority.
仔細觀察我們的所有權數據後發現,前16名股東的總所有權爲50%,這意味着沒有一個股東佔多數。
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar.
儘管研究公司的機構所有權數據是有意義的,但研究分析師的情緒以了解公衆輿論也是有意義的。據我們所知,分析師對該公司沒有報道,因此它可能被忽視了。
Insider Ownership Of Mayinglong Pharmaceutical Group
馬英龍藥業集團的內幕所有權
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
儘管內部人士的確切定義可能是主觀的,但幾乎每個人都認爲董事會成員是內部人士。公司管理層對董事會負責,後者應代表股東的利益。值得注意的是,有時高層管理人員自己也是董事會成員。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常認爲內部所有權是一件好事。但是,在某些情況下,這會使其他股東更難追究董事會對決策的責任。
We note our data does not show any board members holding shares, personally. It is unusual not to have at least some personal holdings by board members, so our data might be flawed. A good next step would be to check how much the CEO is paid.
我們注意到,我們的數據並未顯示任何董事會成員個人持有股份。董事會成員不持有至少部分個人持股的情況很少見,因此我們的數據可能存在缺陷。一個不錯的下一步是檢查首席執行官的薪水是多少。
General Public Ownership
一般公有制
The general public-- including retail investors -- own 44% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
包括散戶投資者在內的公衆擁有該公司44%的股份,因此不容忽視。儘管這種所有權規模可能不足以影響有利於他們的政策決定,但它們仍然可以對公司政策產生集體影響。
Private Company Ownership
私人公司所有權
Our data indicates that Private Companies hold 6.1%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
我們的數據顯示,私營公司持有公司6.1%的股份。可能值得對此進行更深入的研究。如果關聯方,例如內部人士,對其中一傢俬營公司有興趣,則應在年度報告中予以披露。私營公司也可能在公司中擁有戰略利益。
Public Company Ownership
上市公司所有權
It appears to us that public companies own 29% of Mayinglong Pharmaceutical Group. We can't be certain but it is quite possible this is a strategic stake. The businesses may be similar, or work together.
在我們看來,上市公司擁有馬英龍製藥集團29%的股份。我們無法確定,但這很可能是戰略利益。這些企業可能相似,也可能合作。
Next Steps:
後續步驟:
It's always worth thinking about the different groups who own shares in a company. But to understand Mayinglong Pharmaceutical Group better, we need to consider many other factors. To that end, you should learn about the 2 warning signs we've spotted with Mayinglong Pharmaceutical Group (including 1 which is potentially serious) .
擁有公司股份的不同群體總是值得考慮的。但是,要更好地了解馬應龍藥業集團,我們需要考慮許多其他因素。爲此,你應該了解我們在馬應龍製藥集團發現的兩個警告信號(包括一個可能嚴重的警告信號)。
Of course this may not be the best stock to buy. So take a peek at this free free list of interesting companies.
當然,這可能不是最值得買入的股票。因此,來看看這份免費的有趣公司名單吧。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注意:本文中的數字是使用過去十二個月的數據計算得出的,這些數據是指截至財務報表日期當月最後一天的12個月期間。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。